1: Lennard TW, Harris AL, Hales J, Dickinson A, Wolstencroft R, Halcrow P, Shenton BK, McDonald M, Lawrence GF, Taylor RM. A phase I study of immunostimulation and toxicity in patients with colorectal carcinoma using the immunomodulator 3,6-bis(2-piperidinoethoxy) acridine trihydrochloride (CL 246738). Eur J Cancer Clin Oncol. 1989 Nov;25(11):1571-6. doi: 10.1016/0277-5379(89)90299-x. PMID: 2591449.
2: Guimaraes L, Takehara HA, Alvarez JM. Protective effects of 3,6-bis-(2-piperidinoethoxyl) acridine trihydrochloride (CL-246738) in experimental acute Trypanosoma cruzi infection. Trans R Soc Trop Med Hyg. 1988;82(4):579-80. doi: 10.1016/0035-9203(88)90517-2. PMID: 3151414.
3: Ruszala-Mallon V, Silva J, Lumanglas AL, Durr FE, Wang BS. The mechanism of action of a synthetic immunomodulator, 3,6-bis(2-piperidinoethoxy)acridine trihydrochloride (CL 246,738), in natural killer cell activation in animals. Int J Immunopharmacol. 1991;13(7):913-21. doi: 10.1016/0192-0561(91)90044-8. PMID: 1722194.
4: Wang BS, Lumanglas AL, Ruszala-Mallon VM, Durr FE. Induction of tumor- inhibitory macrophages with a novel synthetic immunomodulator, 3,6-bis(2-piperidinoethoxy)acridine trihydrochloride (CL 246,738). J Immunol. 1985 Jul;135(1):679-83. PMID: 3839006.
5: Wang BS, Lumanglas AL, Silva J, Ruszala-Mallon VM, Durr FE. The mechanism of action of 3,6-bis(2-piperidinoethoxy)acridine trihydrochloride (CL 246,738) in the potentiation of natural killer cells. J Immunol. 1986 Oct 15;137(8):2640-5. PMID: 3760570.
6: Lucas J, Raventos-Suarez C, Wang BS, Ruszala-Mallon VM, Gibbons JJ Jr. The effect of 3,6-bis(2-piperidinoethoxy) acridine trihydrochloride (CL 246, 738) on acute graft vs host reactions in mice. Int J Immunopharmacol. 1989;11(7):733-41. doi: 10.1016/0192-0561(89)90127-6. PMID: 2599713.
7: Morahan PS, Pinto A, Stewart D, Murasko DM, Brinton MA. Varying role of alpha/beta interferon in the antiviral efficacy of synthetic immunomodulators against Semliki Forest virus infection. Antiviral Res. 1991 Mar- Apr;15(3):241-54. doi: 10.1016/0166-3542(91)90070-8. PMID: 1653557.
8: Kunder SC, Kelly KM, Morahan PS. Biological response modifier-mediated resistance to herpesvirus infections requires induction of alpha/beta interferon. Antiviral Res. 1993 Jun;21(2):129-39. doi: 10.1016/0166-3542(93)90049-o. PMID: 7687839.
9: Lüllmann-Rauch R. Mucopolysaccharidosis (MPS) in ocular tissues as induced by amphiphilic di-cationic drugs. Lens Eye Toxic Res. 1990;7(3-4):263-79. PMID: 2129218.
10: Black PL, McKinnon KM, Wooden SL, Ussery MA. Antiviral activity of biological response modifiers in a murine model of AIDS. Requirement for augmentation of natural killer cell activity and synergy with oral AZT. Int J Immunopharmacol. 1996 Nov;18(11):633-50. doi: 10.1016/s0192-0561(96)00064-1. PMID: 9089007.